ACTRN12624000797572尚未招募Unknown
RECENTRE: Determining the Acceptability, Safety and Efficacy of The Enhancing Women's Recovery after Cancer Treatment Program.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Confirmed diagnosis of breast or gynaecological cancer (all stages).
- •Have completed intensive cancer treatment more than 4 weeks ago including surgery, chemotherapy, immunotherapy and/or radiotherapy (maintenance therapy as specified by treating team permitted e.g. oral chemotherapy; targeted therapies for example trastuzumab; endocrine therapy; bisphosphonates) and up to 36 months post-intensive treatment.
- •>18 years of age.
- •Received care through any Mater facility.
- •Are residing in Queensland, Australia.
- •Cognitively capable of consent.
- •Have access to the internet with a stable connection.
- •Own, or have access to, a computer, tablet device or smartphone.
- •Willing and able to comply with all study requirements, including intervention, timing, and nature of required assessments.
- •Able to speak and read in English to ensure consent is informed and documentation of participant-reported outcome measures can be adhered to.
- •Voluntary written (electronic) informed consent.
排除标准
- •Those who do not fit the above inclusion criteria.
- •Women who are palliative, or on intensive treatment and/or unlikely to be able to complete the program, or unable to provide informed consent.
- •Any clinical contraindication that precludes safe completion of the program in the judgement of the project team
研究者
相似试验
已完成
不适用
A pilot study to examine the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young peopleAnorexia NervosaACTRN12609000521224Astra Zeneca Australia50
尚未招募
4 期
Transplantation and Diabetes (Transdiab): A Pilot Randomised Controlled Trial of Metformin in pre-diabetes after kidney transplantatioew onset diabetes after kidney transplantatonNew onset diabetes after kidney transplantatonRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - DiabetesACTRN12614001171606Auckland District Health Board200
已完成
不适用
To explore safety and feasibility of mobile teledermoscopy for Queensland residents 50-64 year of age at high risk for melanoma.Skin CancerMelanomaCancer - Malignant melanomaMelanomaSkin CancerACTRN12613000590763Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI)50
尚未招募
Unknown
Safety and Efficacy of Glucagon-like peptide 1 agonists in dialysis patientsEnd stage kidney diseaseRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - DiabetesDiabetesACTRN12623000862640Auckland City Hospital95
已完成
1 期
An Open Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with Androgenetic Alopecia Treated with HMI-115 over a 24-Week Treatment PeriodAndrogenetic AlopeciaACTRN12622000680763Hope Medicine (Nanjing) Co., Ltd16